Drug Discovery Leaders Warn U.S. Cuts Endanger AI Edge
As Washington trims billions from health funding, AI drug discovery leaders warn the timing could widen the gap with ...
This intro covers the worst drawdowns seen in SP 500 index funds, explaining factors behind steep declines and the recovery path.
15,257 articlesAs Washington trims billions from health funding, AI drug discovery leaders warn the timing could widen the gap with ...
Anthropic’s Claude Code chief says he hasn’t manually coded in about eight months, signaling a broader move to AI-dri...
A loomingFed policy shift could push up borrowing costs for households. Analysts warn americans taxpayers could face ...
In a volatile market, Procter & Gamble’s decades-long dividend growth and reliable cash flow position it as a stable ...
Missing pet posts are increasingly targeted by AI-powered scammers. Learn how these schemes work, the warning signs, ...
Federal Reserve Chair Kevin Warsh is signaling a second inflation-fighting tool beyond traditional rate changes. Inve...
A fake bank fraud call can feel urgent and scary. This guide breaks down how scammers operate, how to spot the red fl...
XRP would need a dramatic rally and strong regulatory clarity to reach $20 this cycle. This report weighs the math, t...
Temasek unveils a sweeping leadership overhaul, elevating its CFO into a central strategic role as the group reorgani...
Two midstream ETFs compete on tax structure and cash-flow strategy. A closer look at AMLP and MLPX reveals how holdin...
A major federal loan initiative aims to revitalize nuclear power by backing five new projects with $17.5 billion. Thi...
Micron Technology surged to a fresh all-time high after a blockbuster earnings report and strong AI-driven demand. Th...